These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 3306361

  • 1. N-nitrosamines: bacterial mutagenesis and in vitro metabolism.
    Guttenplan JB.
    Mutat Res; 1987 Sep; 186(2):81-134. PubMed ID: 3306361
    [Abstract] [Full Text] [Related]

  • 2. High mutagenic activity of N-nitrosobis(2-oxopropyl)amine and N-nitrosobis(2-hydroxypropyl)amine in the host-mediated assay in hamsters: evidence for premutagenic methyl and hydroxylpropyl adducts.
    Guttenplan JB, Kokkinakis D.
    Carcinogenesis; 1993 Aug; 14(8):1621-5. PubMed ID: 8353845
    [Abstract] [Full Text] [Related]

  • 3. Mutational specificities of N-nitrosamines in a host-mediated assay: comparison with direct-acting N-nitroso compounds in vitro and an approach to deducing the nature of ultimate mutagens in vivo.
    Liu YX, Guttenplan JB.
    Mol Carcinog; 1992 Aug; 6(4):232-7. PubMed ID: 1485914
    [Abstract] [Full Text] [Related]

  • 4. The superiority of hamster liver microsomal fraction for activating nitrosamines to mutagens in Salmonella typhimurium.
    Lijinsky W, Andrews AW.
    Mutat Res; 1983 Oct; 111(2):135-44. PubMed ID: 6355832
    [Abstract] [Full Text] [Related]

  • 5. Mutagenicity of potassium alkanediazotates and their use as model compounds for activated nitrosamines.
    Hecker LI, Saavedra JE, Farrelly JG, Andrews AW.
    Cancer Res; 1983 Sep; 43(9):4078-82. PubMed ID: 6347365
    [Abstract] [Full Text] [Related]

  • 6. Activation of carcinogenic N-nitrosopropylamines to mutagens by lung and pancreas S9 fractions from various animal species and man.
    Mori Y, Yamazaki H, Toyoshi K, Maruyama H, Konishi Y.
    Mutat Res; 1986 May; 160(3):159-69. PubMed ID: 3960034
    [Abstract] [Full Text] [Related]

  • 7. Metabolism and mutagenicity of N-nitrosohexamethyleneimine and its hydroxylated derivatives.
    Hecker LI, Saavedra JE, Andrews AW.
    Teratog Carcinog Mutagen; 1983 May; 3(1):9-17. PubMed ID: 6132461
    [Abstract] [Full Text] [Related]

  • 8. Investigations on the mutagenicity of primary and secondary alpha-acetoxynitrosamines with Salmonella typhimurium: activation and deactivation of structurally related compounds by S-9.
    Pool BL, Wiessler M.
    Carcinogenesis; 1981 May; 2(10):991-7. PubMed ID: 7028307
    [Abstract] [Full Text] [Related]

  • 9. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
    Mori Y, Yamazaki H, Toyoshi K, Makino T, Obara T, Yokose Y, Konishi Y.
    Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
    [Abstract] [Full Text] [Related]

  • 10. The mutagenicity of nitrosopyrrolidine is related to its metabolism.
    Hecker LI, Elespuru RK, Farrelly JG.
    Mutat Res; 1979 Sep; 62(2):213-20. PubMed ID: 388209
    [Abstract] [Full Text] [Related]

  • 11. DNA binding by [2,5-14C]N-nitrosopyrrolidine in excision-repair proficient and deficient strains of Salmonella. Evidence for a major premutagenic adduct.
    Zielenska M, Guttenplan JB.
    Carcinogenesis; 1988 Oct; 9(10):1901-4. PubMed ID: 3048765
    [Abstract] [Full Text] [Related]

  • 12. Alpha-hydroxylation and mutagenicity of unsymmetrical N-nitrosodialkylamines with a butyl group.
    Suzuki E, Mochizuki M, Takeda K, Okada M.
    Jpn J Cancer Res; 1985 Mar; 76(3):184-91. PubMed ID: 3922836
    [Abstract] [Full Text] [Related]

  • 13. Comparative mutagenicity of N-nitrosamines in a semi-solid and in a liquid incubation system in the presence of rat or human tissue fractions.
    Bartsch H, Camus A, Malaveille C.
    Mutat Res; 1976 Nov; 37(2-3):149-62. PubMed ID: 794701
    [Abstract] [Full Text] [Related]

  • 14. Activation of nitrosamines to mutagens by rat and rabbit nasal, lung and liver S-9 homogenates.
    Dahl AR.
    Adv Exp Med Biol; 1986 Nov; 197():367-72. PubMed ID: 2945408
    [No Abstract] [Full Text] [Related]

  • 15. In vitro metabolic activation of N,N-dibutylnitrosamine in mutagenesis.
    Suzuki E, Mochizuki M, Wakabayashi Y, Okada M.
    Gan; 1983 Feb; 74(1):51-9. PubMed ID: 6341155
    [Abstract] [Full Text] [Related]

  • 16. Mutagenic activation of carcinogenic N-nitrosopropylamines by liver S9 fractions from mice, rats and hamsters: evidence for a cytochrome P-450-dependent reaction.
    Mori Y, Yamazaki H, Toyoshi K, Denda A, Konishi Y.
    Carcinogenesis; 1986 Mar; 7(3):375-9. PubMed ID: 3512116
    [Abstract] [Full Text] [Related]

  • 17. Cytochrome P450 hydroxylation of carbon atoms of the alkyl chain of symmetrical N-nitrosodialkylamines by human liver microsomes.
    Bellec G, Dréano Y, Bail JP, Ménez JF, Berthou F.
    Mutat Res; 1997 Jul 03; 377(2):199-209. PubMed ID: 9247615
    [Abstract] [Full Text] [Related]

  • 18. Metabolic activation capabilities of S9 and hepatocytes from uninduced rats to convert carcinogenic N-nitrosamines to mutagens.
    Rumruen K, Pool BL.
    Mutat Res; 1984 Jul 03; 140(2-3):147-53. PubMed ID: 6379440
    [Abstract] [Full Text] [Related]

  • 19. Studies of the metabolic bioactivation of n-nitrosopyrrolidine in the rat.
    Cottrell RC, Blowers SD, Walters DG, Lake BG, Purchase R, Phillips JC, Gangolli SD.
    Carcinogenesis; 1983 Jul 03; 4(3):311-4. PubMed ID: 6339097
    [Abstract] [Full Text] [Related]

  • 20. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by inducible and constitutive cytochrome P450 enzymes in rats.
    Guo Z, Smith TJ, Thomas PE, Yang CS.
    Arch Biochem Biophys; 1992 Oct 03; 298(1):279-86. PubMed ID: 1524438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.